FORA Capital LLC Sells 32,933 Shares of Humana Inc. (NYSE:HUM)

FORA Capital LLC decreased its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 87.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,584 shares of the insurance provider's stock after selling 32,933 shares during the quarter. FORA Capital LLC's holdings in Humana were worth $1,163,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Transcend Capital Advisors LLC lifted its holdings in Humana by 399.7% in the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock valued at $924,000 after buying an additional 2,914 shares during the period. FNY Investment Advisers LLC lifted its stake in shares of Humana by 6,647.5% in the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock valued at $6,916,000 after purchasing an additional 26,856 shares during the period. Retirement Systems of Alabama boosted its position in shares of Humana by 735.9% during the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after purchasing an additional 192,801 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its position in shares of Humana by 7.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock valued at $244,811,000 after purchasing an additional 65,735 shares in the last quarter. Finally, Secure Asset Management LLC bought a new stake in Humana in the fourth quarter worth approximately $244,000. Institutional investors and hedge funds own 92.38% of the company's stock.

Wall Street Analyst Weigh In

HUM has been the topic of a number of research analyst reports. Cantor Fitzgerald restated a "neutral" rating and set a $290.00 price target on shares of Humana in a report on Thursday, May 1st. Truist Financial cut their target price on shares of Humana from $325.00 to $305.00 and set a "hold" rating on the stock in a research note on Monday. Robert W. Baird lifted their price target on shares of Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a research note on Tuesday, April 15th. Royal Bank of Canada reiterated an "outperform" rating and set a $283.00 price objective on shares of Humana in a report on Wednesday, February 12th. Finally, StockNews.com upgraded Humana from a "hold" rating to a "buy" rating in a research note on Friday. Seventeen equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, Humana presently has an average rating of "Hold" and an average price target of $286.81.

Humana Stock Up 1.2%

Shares of NYSE HUM traded up $2.94 during trading on Monday, hitting $252.47. The stock had a trading volume of 1,425,098 shares, compared to its average volume of 1,744,235. The firm has a fifty day moving average of $265.02 and a two-hundred day moving average of $270.41. The company has a market capitalization of $30.47 billion, a PE ratio of 25.37, a PEG ratio of 2.05 and a beta of 0.49. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. Humana had a net margin of 1.02% and a return on equity of 11.70%. The business had revenue of $32.11 billion during the quarter, compared to the consensus estimate of $32 billion. During the same period in the prior year, the firm posted $7.23 EPS. The firm's quarterly revenue was up 8.4% compared to the same quarter last year. As a group, equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a $0.885 dividend. The ex-dividend date is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a yield of 1.40%. Humana's dividend payout ratio (DPR) is presently 25.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.